BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 16791836)

  • 1. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte responses to heterologous secondary dengue virus infections.
    Rothman AL
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
    Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue viral infections.
    Malavige GN; Fernando S; Fernando DJ; Seneviratne SL
    Postgrad Med J; 2004 Oct; 80(948):588-601. PubMed ID: 15466994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue and dengue haemorrhagic fever: implications of host genetics.
    Chaturvedi U; Nagar R; Shrivastava R
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):155-66. PubMed ID: 16831202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
    Appanna R; Huat TL; See LL; Tan PL; Vadivelu J; Devi S
    Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
    Beaumier CM; Mathew A; Bashyam HS; Rothman AL
    J Infect Dis; 2008 Feb; 197(4):608-17. PubMed ID: 18275279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of Dengue hemorrhagic fever.
    Rothman AL; Ennis FA
    Virology; 1999 Apr; 257(1):1-6. PubMed ID: 10208914
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation.
    Cheng HJ; Lei HY; Lin CF; Luo YH; Wan SW; Liu HS; Yeh TM; Lin YS
    Mol Immunol; 2009 Dec; 47(2-3):398-406. PubMed ID: 19822367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
    Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
    J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage.
    Fadilah SA; Sahrir S; Raymond AA; Cheong SK; Aziz JA; Sivagengei K
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):710-7. PubMed ID: 10928365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
    Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
    J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.
    Ubol S; Masrinoul P; Chaijaruwanich J; Kalayanarooj S; Charoensirisuthikul T; Kasisith J
    J Infect Dis; 2008 May; 197(10):1459-67. PubMed ID: 18444802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S; Paci M
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.